NEWS: Amerge Cleocin Fioricet Cefixime! Diamox Dutasteride Foradil Lamisil Leflunomide Ciprofloxacin Diethylpropion Digoxin? Losartan Meridia Levlen Prempro Premphase Aricept Oseltamivir Mometasone! Phentermine Ionamin Crestor Accupril Diovan Neurontin Clomiphene Hydrocodone? Esomeprazole Phendimetrazine. Cyclobenzaprine Lisinopril. Minipress Enalapril Altace Diethylpropion Azithromycin Accolate Pravastatin Celebrex Encare Famvir Celebrex Flovent Hydroxyzine Furosemide. Advair Coreg Nortriptyline Pediacare: Clopidogrel Altace Aldara Avalide Aldactone Estraderm Buspirone Percocet Dovonex Avandamet Gemfibrozil Noroxin Avandamet Plendil Clonazepam Famotidine Afrin Minocin Fosamax Ceclor! Muse Lansoprazole Femara Aciphex Paxil Beconase Naprosyn Crestor? Cleocin Paroxetine Fastin Combivent! Klonopin Atorvastatin Apomorphine Insulin! Indapamide Naprosyn Famvir Ibuprofen Cosopt Atrovent Lamisil Cordarone Cytomel Bromocriptine Beconase Azithromycin Differin Glucophage! Vicodin Cardizem Meridia Indapamide Oxycodone Ambien. Allegra Fioricet Flomax Pravachol Pantoprazole Amoxil Keflex Feldene Prempro Pioglitazone Catapres Aldactone Ionamin Pentasa Ditropan Levothyroxine Lysodren Arava Clomipramine Macrodantin. Lozol Aldara, Methylphenidate Ditropan Zithromax Cephalexin: Kaopectate Flexeril Flutamide Ansaid Ceclor Lanoxin! Multivitamins Nitrofurantoin Amiloride Adapalene, Mometasone Mobic Prednisone Lysodren Alka seltzer Lozol, Noroxin Diflucan Famotidine Celecoxib Alavert Augmentin Itraconazole Lopid? Diprolene Fastin? Bayer Hydroxyurea: Divalproex Nolvadex: Locoid Tramadol Metoprolol Diprolene? Hydrochlorothiazide Cipro Lovastatin Lamotrigine Prevacid Cytotec Ampicilin Citalopram Cimetidine Chromium Lisinopril Mevacor Arimidex Bactrim Ecotrin Cetirizine Ephedrine Muse Lodine Flutamide Permax Caffeine Nicorette Prevacid? Donepezil Differin Imuran Clopidogrel Losec Ecotrin Amaryl Metformin! Cephalexin Esomeprazole Accupril Diamox, Premarin Levofloxacin, Avapro Cytomel! Colace Claritin. Flonase Asa Gabapentin Amlodipine Naproxen Lamictal Atorvastatin Losec Lopressor Clomipramine. Anafranil Piroxicam Estraderm Lorazepam, Hyzaar Lotrimin Amoxicillin Paxil Botox Glyburide Lexapro Glucotrol Bupropion Dovonex Pediacare Divalproex Coreg Dilantin Piroxicam Nicotrol! Bromocriptine Imuran! Calan Imodium Methocarbamol Lasix Pravachol Alavert Accolate Clomiphene Enalapril Mycostatin Estrace Lexapro Carvedilol Metoprolol Amoxil Glipizide Atropine Methylphenidate, Finasteride Aspirin Arthrotec Levoxyl Epivir Letrozole Nolvadex Locoid Glucophage Avapro! Diflucan Nystatin Glipizide Flomax: Lamictal Ativan Plaquenil Plaquenil. Celecoxib Buspirone Doxycycline Lopressor, Percocet Lithium Asa Fluvastatin Fluconazole Femara Clomid Amphetamine. Flagyl Losartan Insulin Elocon Diclofenac Loprox Chlortrimeton Eulexin Nifedipine Nabumetone, Levitra Hydrocortisone Clarithromycin Viagra Orlistat Indocin Ativan Isotretinoin! Cetirizine Carisoprodol Nexium Imiquimod Flovent Gemfibrozil: Viagra Imdur Cardura Botox, Furosemide Inderal Lamotrigine Orlistat. Alendronate Cope Ambien Allegra Lorazepam Alprazolam Lopid Levitra, Luvox Aerobid Lanoxin Allopurinol Adipex Olanzapine Elidel Bayer Alesse Dulcolax: Atrovent Hydrochlorothiazide Imdur Pepcid Imodium Epo Imiquimod Motrin, Nystatin Bentyl! Estrogen Nadolol. Nicotrol Coumadin? Maxzide Gabapentin Ciprofloxacin Exelon Fluvastatin Climara Effexor Hyzaar. Oxycontin Prazosin: Aerobid Chlortrimeton Androgel Epivir Plendil Premarin Combivent Avodart: Fluoxetine Levlen Nasonex Encare, Prazosin Fluticasone Caffeine Elavil: Epo Alendronate Actos Nicorette Elocon Amoxicillin! Inderal Afrin Hydroxyurea Methocarbamol, Biaxin Flagyl! Prinivil Naltrexone! Diltiazem Budesonide Indomethacin Monopril Accutane Keflex. Neurontin Hytrin Celexa Donepezil Plavix Nifedipine: Macrobid Cafergot: Tramadol Lovastatin Macrodantin Capoten Lescol Doxycycline Glucotrol Phentermine: Claritin Hydroxyzine, Cordarone Clindamycin: Pepcid Albuterol Diazepam Micronase. Dilantin Zithromax Codeine Apomorphine! Bentyl Naproxen Citalopram Nizoral Carbamazepine Celexa: Lithium Ketoconazole Aspirin Oseltamivir Pioglitazone Fluoxetine. Eldepryl Phenytoin Levaquin Adalat Naltrexone Amitriptyline Clarinex Potassium Bactrim Carvedilol Captopril Estrogen Digoxin Estrace

Archive for October, 2007

Marketing Can Radically Impact Sales

Wednesday, October 31st, 2007

A quote caught my eye in Jill Konrath’s new e-book Selling to Big Companies. “As a sales purist, it’s hard to admit that no matter how hard I work with my corporate clients to improve their sales effectiveness, it’s just not enough anymore. Sales desperately needs marketing to take the lead and up the ante.

Wow! Are we witnessing a B2B marketing renaissance here? The e-book goes on to outline a five-point approach for B2B marketing to “radically” impact sales

  1. Radically embrace a thought-leadership mindset.
  2. Radically optimize lead generation and lead nurturing.
  3. Radically develop a sales enablement portal.
  4. Radically leverage sales intelligence.
  5. Radically invest in this change now.

For the whole e-book, download at www.sellingtobigcompanies.com.

Words that Work…

Thursday, October 25th, 2007

“Words That Work: It’s Not What You Say, It’s What People Hear” - Frank Luntz

Is a rose as sweet by any other name? Apparently not, according to Frank Luntz in his blockbuster book. From electing Presidents to garnering support for Social Security reform to gaining advocacy for the Oil & Gas Industry or for Pfizer Pharmaceuticals, Luntz has tested the words that work and the ones that don’t in politics, in labor relations and in industry.

Luntz doesn’t talk generalities; he gives you the numbers. For example, 17% more Americans favor eliminating the “Death Tax” than favor eliminating the “Inheritance Tax” – even though they are the same thing. Luntz shows how industries have rebranded themselves by changing their names: from gambling to gaming, liquor to spirits and banks to credit unions. Even Newt Gingrich relies on Frank’s Ten Rules of Effective Language to get his message through.

As marketing communicators, can we ignore these realities? Read “Words that Work.” Then you decide.

$5 worth of media training

Monday, October 22nd, 2007

CNN and other major media outlets recently ran stories on the U.S. government introducing the redesign of the $5 bill, which the Bureau of Printing and Engraving did via online press conference. (more…)

Does Your Marketing Suck?

Wednesday, October 17th, 2007

What ROI are you getting for your marketing bucks? 

The book, “Your Marketing Sucks,” really puts it to you. Author Mark Stevens doesn’t mince words. He’s a slick New York ad agency guy who’s not shy about getting to his key point: “If you aren’t getting a known ROI on your marketing bucks…your marketing sucks.”

Admittedly, the author is not a B2B marketing specialist. Yet a good portion of what he’s pushing makes sense for all of us. Stevens claims traditional agencies offer “lazy marketing,” which is marketing done with no strategy to increase sales or business profitability.

In our view, once you get past the outrageous title, the book is well worth the read. “Your Marketing Sucks” urges you to expect more, demand more and so get more for every marketing dollar you spend. Now that’s an idea that certainly doesn’t suck.

Sales Team vs. E-commerce - let the B2B battle begin

Friday, October 12th, 2007

NBC’s “The Office” delved deeper into the evolving world of B2B last night as the paper company’s new e-commerce Web site officially launched. This sparked a true galactic battle as Dunder Mifflin’s top salesman vowed to beat the Web site’s sales for a day. Despite the humor and obvious jabs at B2B being behind the times, this raises a valid question, “Can sales teams and e-commerce co-exist?”

My answer, “Of course they can!” (more…)

Is your marketing suffering from the “7 Year Itch”?

Tuesday, October 9th, 2007

It struck me recently that marriage and marketing have at least one thing in common: both of them work best when they have open and honest communications. (more…)

B2B Marketing - Hit Home Runs, Not Pop-ups

Tuesday, October 9th, 2007

You’ve heard the 50 year old quote “Half of our advertising is working. We just don’t know which half.” Yet, it’s astonishing how many CEOs at B2B companies still accept vague marketing performance as a fact of life.

Batting 500 may be great in baseball, but not in marketing or sales. CEOs have to demand that every marketing activity has a measurable ROI. No more strikeouts. No more pop ups. Marketing objectives like branding and positioning are simply a means to an end. The true measure of marketing success has to be sales success. 

In today’s Internet-enabled world marketing has to be held accountable. Why? Because B2B buyers have changed. They no longer wait for sales people to inform them about products. They are more independent. According a July 2007 survey of buyers in the chemical industry, less than 28% said they rely on sales people for information on new products. Buyers are out there on the web beginning the buying process long before your sales people call. Without marketing, you will be left on the bench. So be aware. Be demanding. Be a winner.

“The Office” brings comedy to B2B

Friday, October 5th, 2007

For those who don’t watch The Office, the sitcom parodies the 9-to-5 business world through the lives of employees at Dunder-Mifflin — a B2B company in the paper industry. In this season’s second episode, the company faces a top executive who wants to bring Dunder-Mifflin into the digital age with a new Web site to replace one that has long been under construction. The chaos that ensues is the sitcom’s own irreverent way of showing how B2B companies often struggle to adapt to new technologies that will help boost sales.

(more…)

How one can avoid the unofficial, unqualified “Top Ten Lies Public Relations Agencies Tell Their Clients and Prospects”

Thursday, October 4th, 2007

Although I’m sure that the leadership of this PR agency trying to educate the world about the “Top 10 Lies a PR Firm Will Tell their Customers and Prospects” only had the best interest of others in mind when writing and distributing this press release, I’m curious to find out what they actually deemed to be newsworthy or, for a matter of fact, of any value at all. Or is that not a qualification for press releases distributed by their agency? If so, maybe they should add an 11th lie to their list, being “Yes! This would definitely make a good press release.” (more…)